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Abstract
Heterogeneity amongst dendritic cell (DC) subsets leads to a spectrum of immune response capacity against pathogens.
Several DC subsets in spleen have been described which differ in terms of phenotype and function. We have previously
reported a distinct population of CD11cloCD11bhiMHC-II2CD82 dendritic-like ‘‘L-DC’’ in murine spleen, which can also be
generated in splenic stromal longterm cultures. Here, the ontogeny of L-DC development in perinatal mice has been
compared with other known splenic DC subsets. Flow cytometric analysis has revealed the presence of L-DC at embryonic
age (E)18.5 spleen, while plasmacytoid (p)DC and conventional (c)DC appear at 2 and 4 days following birth. Co-cultures of
E18.5 spleen above splenic stroma also showed production of only L-DC, while spleen cells from D0 through D5 neonates
showed production of both L-DC and cDC-like cells. Addition of an M-CSFR inhibitor to co-cultures revealed that while the
development of cDC-like cells depended on M-CSF, many L-DC developed independently of M-CSF. Furthermore, purified
hematopoietic stem cells (HSC) and multipotential progenitors (MPP) isolated from neonatal D1 spleen are capable of
developing into L-DC in co-cultures. These studies reveal a lineage of dendritic-like cells developing in the spleen
microenvironment, and which appear to arise from endogenous progenitors laid down in spleen during embryogenesis.
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Introduction
Hematopoiesis in fetal spleen occurs at around embryonic day
(E)14.5. Hematopoietic stem cells (HSC) in fetal spleen have
limited proliferative ability, and a small number of HSC and
immediate progenitors also emigrate from fetal liver to spleen [1].
Spleen hematopoiesis is believed to be restricted to production of
erythyrocytes with minor myeloid lineage development, particu-
larly dendritic cells (DC) [2]. However, the development of DC
during embryogenesis and perinatal life has not been fully
investigated.
Several studies have now demonstrated the presence of HSC in
steady-state adult spleen, albeit in low numbers [1,3,4]. Osteo-
blastic and vascular niches are sites of HSC maintenance,
proliferation and differentiation in bone marrow (BM), but the
splenic niche for HSC has not been well defined [5]. The spleen
contains only vascular niches and no osteoblastic sites, so the
maintenance and differentiation of HSC in the spleen microen-
vironment may be mechanistically different to that of BM. Indeed,
while splenic stromal cells have been found to express signaling
molecules similar to those described in BM hematopoietic niches
[6], it has been determined that HSC cannot be maintained in
E14.5 fetal spleen organ cultures [7]. Here we describe a murine
spleen stromal cell line derived from a 6-day old (D6) mouse spleen
which does support hematopoiesis, but only of dendritic-like cells
[8,9,10].
In the steady-state, adult spleen contains several commonly
known DC subsets including conventional (c)DC, plasmacytoid
(p)DC and monocyte-derived DC whose development relies on the
continuous supply of immediate DC precursors seeding through
blood from BM to spleen, where they complete their development
in the spleen microenvironment [11]. While these DC subsets are
now well described in the literature, they are readily distinguish-
able from a smaller subset of dendritic-like cells which we have
described: a CD11bhiCD11cloMHC-II2 splenic subset called ‘‘L-
DC’’ which are also F4/80+Ly6C24-1BBLlo [12,13] (also unpub-
lished data). These cells are distinct in that they induce CD8+ T
cell responses, but do not activate CD4+ T cells. Previous studies
had shown that long-term cultures (LTC) of neonatal spleen
maintained production of similar dendritic-like cells called ‘‘LTC-
DC’’ over years, suggesting that they may be derived from self-
renewing progenitors [14,15,16]. Cloned splenic stroma derived
from LTC have since been shown to support development of
equivalent cells called ‘‘L-DC’’ from overlaid lineage-depleted
(Lin2) BM or purified HSC [8,17,18]. When cells produced in co-
cultures or LTC were collected and sorted, the CD11b2CD11c2
subset was found to contain L-DC progenitors and could re-seed
stroma for L-DC production [8,9]. The CD11c+CD11b+ subset
could not however, and overlaid cells died without differentiating
further. In a previous study it was also confirmed that L-DC do
not derive from a monocyte or myeloid precursor since
CD11b+MHC-II2 cells from spleen did not seed stromal co-
cultures for hematopoiesis [19].
The in vivo equivalent of L-DC is now characterised in adult
spleen [12], and L-DC are distinct from splenic cDC and pDC in
terms of their phenotype, their high endocytic capacity, and their
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capacity for cross-presentation of antigen to CD8+ T cells [13,18].
L-DC are also distinct from monocytes, and in particular a
CD11bloCD11cloMHC-II2 subset of small (FSClo) spleen cells
which others have classified as ‘‘residential monocytes’’ [20,21]
and which we tentatively classified as ‘‘DC precursors’’ [12], since
they reflect a heterogeneous population of CD11c+ cells. L-DC are
distinct from this subset in that they have a distinct FSChi profile,
are highly endocytic and can cross present antigen which the
CD11bloCD11cloMHC-II2 cells cannot do [12].
The possibility that spleen maintains endogenous progenitors of
L-DC is of immense biological interest in terms of tissue-specific
hematopoiesis, and the possible production of spleen-specific
antigen presenting cells having tissue-specific function. Indeed,
their development may be attributable to the development of
stromal niches during the neonatal period, and the influx of
hematopoietic progenitors into tissues during embryogenesis. The
ontogeny of L-DC development in perinatal spleen has been
determined here in relation to other known cDC and pDC subsets.
The presence of L-DC progenitors in neonatal spleen was also
tested by overlaying cells in co-cultures above 5G3 stroma. The
importance of Flt3L, GM-CSF and M-CSF for L-DC develop-
ment in spleen has also been considered in light of evidence for the
role of these factors in the development of cDC and pDC.
Materials and Methods
Ethics Statement on Animals
Animal housing, handling and experimentation was approved
by the Animal Experimentation Ethics Committee (Australian
National University, Canberra, Australia) and experiments per-
formed under protocol number A2013/11. Specific pathogen free
female C57BL/6J mice were bred at the John Curtin School of
Medical Research (JCSMR) (Canberra, Australia). Animals were
sacrificed by cervical dislocation.
Antibodies
Purified antibodies specific for CD3e (145–2C11), CD4 (L3T4),
CD5 (53–7.3), CD8 (53–6.7), B220 (RA3–6B2), Gr-1 (RB6–8C5),
Ter119 (Ter-119), CD16/32 (93) and Mac-1 (M1/70) were
obtained from eBioscience (San Diego, CA, USA). Fluorochrome-
conjugated antibodies specific for CD11c (N418), CD11b (M1/
70), and streptavidin-APC-Cy7 were obtained from eBioscience.
Fluorochrome-conjugated antibodies specific for CD3 (145–
2C11), CD8 (53–6.7), CD19 (MB19–1), Gr-1 (RB6–8C5),
Ter119 (Ter-119), B220 (RA3–6B2), Ly6C (AL-21), Ly6G (1A8),
MHC-II (AF6–120.1), F4/80 (C1: A3–1), c-kit (2B8), Sca1 (E13–
161.7), Flt3 (A2F10), CD150 (TC15–12F12.2), 4–1BBL (TKS-1),
streptavidin-PE-Cy7, streptavidin-PE and streptavidin-FITC were
obtained from Biolegend (San Gabriel, CA, USA). Isotype control
antibodies including Rat IgG2a (R35–95), Rat IgG2b (RTK4530),
Rat IgG2b (eB149/10H5), Mouse IgG2a (eBM2a) and Hamster
IgG (eBio299Arm) were obtained from eBioscience. All antibodies
were titrated prior to use to determine concentration giving
minimum saturation binding.
Cell Culture and Reagents
Cells were cultured in DMEM supplemented with 4g/L D-
glucose, 6mg/L folic acid, 36mg/L L-asparagine, 116mg/L L-
arginine, to which was added 10% FCS, 10mM HEPES, 2mM L-
glutamine, 100U/L penicillin, 100ug/L streptomycin and
561025M 2-mercaptoethanol. The splenic stromal cell line 5G3
[22,23] was passaged every 4 days by scraping and transferring
non-adherent cells to a new flask. Cells were maintained in 5%
CO2 in 95% humidity at 37uC.
Preparation of T/B Depleted Spleen Cells
A suspension of T and B cell depleted adult spleen cells was used
for DC subset analysis and co-culture above 5G3 stroma.
Biotinylated antibodies specific for CD19 (eBio1D3: mouse IgG2a)
(eBioscience), Thy 1.2 (30-H12: rat IgG2b) (Becton Dickinson: San
Diego, CA, USA) and Ter-119 (TER-119: rat IgG2b) (Biolegend)
were used to remove red blood cells as well as T and B lineage
Figure 1. Characterization of splenic DC subsets. (A) Perinatal
and adult spleen cells from C5BL/6J mice were stained with antibodies
to distinguish DC subsets flow cytometrically. The procedure for gating
subsets in one adult mouse is shown by example. Propidium iodide (PI)
staining was used to discriminate dead cells. Gates were set on bivariate
plots using isotype control antibodies and numbers on gates reflect %
positive cells. CD11b and CD11c staining was used to identify
CD11bhiCD11c2, CD11bhiCD11clo, CD11b+CD11chi and CD11b2CD11c+
subsets. Further staining for CD8, MHC-II and B220 was used to
distinguish CD8+ cDC and CD82 cDC, L-DC, myeloid cells, and pDC. (B)
The proportional representation of myeloid and DC subsets amongst
the total CD11b+ and/or CD11c+ dendritic/myeloid population is
shown. Data were derived using average values obtained for 2 mice.
E = embryonic; D= day post birth.
doi:10.1371/journal.pone.0088311.g001
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cells. For these experiments, antibodies to Thy1.2, CD19, and
Ter119 were absorbed to 107 cells followed by incubation on ice
for 20 minutes. The cell suspension was then washed twice with
labeling buffer by centrifugation at 300 g and 4uC for 5 minutes.
The supernatant was discarded completely and cells resuspended
in 20 ul of MACSH anti-biotin microbeads (Miltenyi Biotech:
Gladbach, Germany). Cells were further incubated on ice for 20
minutes. Following incubation, cells were washed twice with 10 ml
labeling buffer by centrifugation at 300 g and 4uC for 5 minutes.
The supernatant was completely decanted and cell pellets
resuspended in 500 ul labeling buffer. Cell suspension was
transferred to a MACSH MS column for cell separation.
Co-culture of Spleen Cells Over 5G3 Stroma
For establishment of co-cultures, spleen cells (104–5 cells/ml)
were overlaid on to near-confluent 5G3 stroma in replicate 25 cm2
flasks (5 ml). Medium change was performed every 3–4 days by
discarding 2.5 ml medium and replacement with 2.5 ml fresh-
warmed complete medium. Non-adherent cells produced in co-
cultures were collected at days 14, 21 and 28 for analysis of cell
subsets produced. In the M-CSFR inhibition study, 104–5 cells/ml
sorted longterm (LT)-HSC and multipotent progenitors (MPP)
from one-day old spleen of C57BL/6J mice were overlaid on to
5G3 stroma in the presence and absence of 10 nM GW2580, an
M-CSFR inhibitor (BioVision, CA, USA). Non-adherent cells
were then collected at days 14, 21, and 28 for analysis of cells
produced.
Cytokine-induced Production of DC
Whole BM or spleen cells were resuspended at a final
concentration of 16106 cell/ml in RPMI 1640 medium supple-
mented with 10% FCS, 561024 M 2-mercaptoethanol, 10 mM 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES),
100 U/ml penicillin, 100 ug/ml streptomycin (sRPMI 1640).
Flt3L (Genzyme: Cambridge, MA, USA) was added to cultures
at a final concentration of 200 ng/ml. GM-CSF (Genzyme) was
added at a final concentration of 10 ng/ml, and IL-4 (Genzyme) at
0.3 ng/ml. Cells were maintained at 37uC, 5% CO2 in air and
95% humidity. Medium was changed by replacing half of aged
medium with fresh warm sRPMI 1640 medium supplemented
with cytokines as described above. GM-CSF/IL-4 cultures were
collected by vigorously shaking the flask with removal of
supernatant at 7 days, while cells in Flt3L cultures were collected
at 9 days for analysis of surface marker expression by antibody
staining and flow cytometry.
Figure 2. Production of dendritic-like cells in co-cultures established with perinatal spleen. (A) Co-cultures of E18.5, D0, D2, D4, D5 and
adult spleen cells were established over 5G3 stroma. Cell production was assessed after 14, 21 and 28 days using antibody staining and multicolor
flow cytometry. Gates were set on bivariate plots using isotype control antibodies and numbers on gates reflect % positive cells. Production of CD11c
and CD11b distinct subsets was calculated in terms of the relative proportion of each. (B) Production of CD11bhiCD11cloMHC-II2 L-DC, and
CD11bhiCD11chiMHC-II+ cDC-like cells was calculated in terms of the relative proportion amongst the total CD11c+ and/or CD11b+ cells.
doi:10.1371/journal.pone.0088311.g002
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Isolation of Hematopoietic Progenitors from Neonatal
Spleen
Spleen cells from one-day old mice were stained with antibodies
for delineation of progenitors for sorting. A cocktail of antibodies
was used to sort Lin (CD3, CD4, CD5, CD8, B220, Gr-1, CD11b,
Ter118, CD11c) 2 cells. LT-HSC were sorted as Lin2Sca-1+c-
kit+Flt32CD150+ cells [21]; MPP as Lin2Sca-1+c-
kit+Flt3+CD1502 [24]; sorting was performed on a FACSAria II
flow cytometer (Becton Dickinson), and sorted cells reanalysed to
check purity. Isotype control antibodies were used to set gates and
propidium iodide (PI: 1 ug/mL) staining of cells was used for dead
cell discrimination. Sorted cells were washed twice and overlaid on
to 5G3 stroma for assessment of cell production.
Analysis of Cells Produced in Co-cultures
Cells collected from co-cultures at each time point were stained
with antibodies specific to dendritic and myeloid cells. Briefly, 105–
6 cells were firstly incubated with purified CD16/32 antibody for
15 min to block surface Fc receptors. After incubation, cells were
washed with DMEM/1%FCS/0.1%NaN3 and then stained with
primary antibodies specific for CD11c, CD11b, CD8, B220 and
MHC-II for 20 min on ice. In some experiments, Ly6C, Ly6G,
F4/80 and 4-1BBL were used to detect specific subsets in co-
cultures. Secondary antibodies were added to the stained cells after
a washing step, and further incubated for 20 min on ice. Stained
cells were finally washed twice and resuspended in 70 ul sDMEM/
1%FCS/0.1%NaN3 in FACS cluster tubes. Cells were stained
with PI (1 ug/ml) for live cell discrimination. Cell acquisition was
performed using a LSRII flow cytometer (Becton Dickinson).
Between 56104 and 106 events were collected for each sample.
Gates were set to delineate cell subsets using isotype control
antibodies and fluorescence minus one controls. Cell subset
analysis was performed using BD FACSDiva Software (Becton
Dickinson) and FlowJo Software (Tristar; Phoenix, Arizona, USA).
Figure 3. Production of DC in Flt3L and GM-CSF/IL-4 supplemented cultures of spleen. (A) D0, D2, D4, D5, D6, D7 and adult spleen cells
were cultured with Flt3L or GM-CSF/IL-4. Cell production was assessed using antibody staining and multicolor flow cytometry. Gates were set on
bivariate plots using isotype control antibodies, and numbers in gates reflect % positive cells. Production of CD11b+CD11c2 and CD11b+CD11c+ cells
was calculated in terms of proportion of each subset amongst all CD11c+ and/or CD11b+ cells. Representation of CD11b+CD11c+MHC-II2 (L-DC) and
CD11b+CD11c+MHC-II+ (cDC-like) cells was calculated in terms of proportion amongst CD11b+CD11c+ cells. (A) Proportion of cells induced by Flt3L.
(B) Proportion of cells induced by GM-CSF/IL-4.
doi:10.1371/journal.pone.0088311.g003
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Results
L-DC Appear Earlier than cDC and pDC in Neonatal
Spleen
Perinatal spleen cells were assessed by antibody staining and
flow cytometric analysis in order to identify DC subsets in
comparison with adult spleen. Analysis involved initial gating of
cell subsets differing in expression of CD11b, CD11c, MHC-II,
B220 and CD8. The CD11bloCD11chiMHC-II+ subset was
divided on the basis of CD8 expression to give CD8+ and
CD82 cDC subsets. The CD11bhiCD11cloMHC-II2CD82 subset
was delineated as L-DC [12]. CD11b+CD11c2MHC-II2CD82
cells were distinguished as myeloid cells. The CD11b2CD11c+
subset was further distinguished as a
CD11b2CD11c+B220+MHC-II+pDC (Fig. 1A).
Analysis of DC subsets appearing in perinatal spleens revealed
L-DC appearing as early as E18.5, while pDC and cDC appeared
at D2 and D5, respectively. CD11b+CD11c2CD82MHC-II2
myeloid cells predominated during early spleen development from
E18.5 to adult. One explanation for the presence of L-DC but not
cDC and pDC in E18.5 spleen, is that L-DC in perinatal spleen
might derive from endogenous progenitors laid down in spleen
during embryogenesis (Fig. 1B). Indeed, L-DC might develop from
yolk sac-derived HSC which enter spleen during embryogenesis.
The cDC and pDC subsets are known to derive from BM
precursors which enter spleen for further development [25].
Pre-natal Spleen Contains only L-DC Progenitors
The presence of progenitors of DC subsets was then investigated
in perinatal spleen. Co-cultures were established by overlay of red
blood cell lysed perinatal spleen cells on 5G3 stroma with flow
cytometric assessment of the production of L-DC and cDC-like
cells. The small tissue size precluded further purification of spleen
cell suspensions. Gates were used to delineate DC
(CD11b+CD11c+), myeloid cells (CD11b+CD11c2) and progeni-
tors (CD11b2CD11c2). DC could be distinguished as two subsets
of L-DC (CD11bhiCD11c+MHC-II2) and cDC-like cells
(CD11b+CD11chiMHC-II+). Co-cultures of E18.5 spleen were
shown to maintain 50–80% of cells as DC, with 20–45% myeloid
cells varying slightly over time. Co-cultures of D0, D2, D4, D5 and
adult spleen also maintained a majority of DC with variable
numbers of myeloid cells and increasing numbers of progenitors
(Fig. 2A). Data are presented in terms of % subset representation
amongst total dendritic and myeloid cells rather then absolute cell
numbers since spleen size, and cell composition varies in spleens of
different perinatal age. In terms of DC subsets produced, E18.5
spleen co-cultures produced only L-DC, while a subpopulation of
cDC-like cells was observed along with L-DC in D0, D2, D4, D5,
D7 and adult spleen co-cultures (Fig. 2B). Also of note is a biphasic
peak in appearance of L-DC in cultures established from E18.5
and D4 spleen. It is tempting to propose that the higher
productivity of L-DC at these times reflects cell development
from primitive HSC (E18.5), and then later from definitive HSC
(D4). These data also indicate the presence of only L-DC
progenitors in pre-natal E18.5 spleen, with almost no evidence
of cDC progenitors (Fig. 2B). After birth, precursors of cDC-like
cells appeared in spleen.
In vitro Induction of DC Using Flt3L and GM-CSF
In order to investigate DC development more fully, the
presence of DC precursors responsive to Flt3L and GM-CSF/
IL-4 was investigated over the perinatal period in in vitro cultures
of neonatal spleens, since these factors are known to regulate DC
development from both in vivo and in vitro studies [26,27]. Spleen
cells from D0, D2, D4, D5 and D7 mice were cultured in the
presence of Flt3L, and cell production compared with cultures
from adult mice. Since all cultures produced equivalent numbers
of cells under the culture conditions imposed (data not shown), cell
production was compared in terms of % subset representation.
The production of DC as CD11b+CD11c+ cells was higher than
the production of CD11b+CD11c2 myeloid cells across this period
(Fig. 3A). Cells were collected for detection of
CD11b+CD11c+MHC-II2 L-DC and CD11b+CD11c+MHC-II+
cDC-like subsets. Flt3L cultures maintained levels of 50–97% of
MHC-II+ cDC-like cells, with a lower 3–50% population of
MHC-II2 L-DC-like cells across all ages of mice (Fig. 3A). Further
Figure 4. Phenotype of DC derived from adult spleen cells cultured with Flt3L or GM-CSF/IL-4. Spleen cell cultures were supplemented
cultures with Flt3L and GM-CSF/IL-4 were analysed for production of CD11c+CD11b+ DC. These subsets were further distinguished by expression of
MHC-II, F4/80, Ly6C, CD8, Ly6G and B220.
doi:10.1371/journal.pone.0088311.g004
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staining revealed production of a minor subset of
CD11b+CD11c+MHC-II2cells which express F4/80 consistent
with L-DC production (Fig. 4). However, not all MHC-II2 cells
are L-DC since 40% express Ly6C, which is a marker of
monocyte-like cells. Flt3L cultures therefore produce a mixture of
cell types including a minor population of CD8+ cDC as reported
previously (Fig. 4) [27]. However, no granulocytes (Ly6G) or
plasmacytoid DC (B220) were detected. Therefore, Flt3L cultures
are more conducive to the development of cDC than L-DC, and
precursors are present from D0 to D7 embryos, and in adults. The
presence of precursors contrasts with the absence of detectable
numbers of cDC in spleens until D5, and then in very low
numbers (Fig. 1B).
Similar spleen cultures supplemented with GM-CSF and IL-4
also produced equally high numbers of cells so that cell production
was compared in terms of proportional subset representation.
Cultures maintained 20–60% populations of CD11b+CD11c2
myeloid cells with lower representation of CD11b+CD11c+ DC
particularly from D0 to D5 (Fig. 3B). The proportion of
CD11b+CD11c+MHC-II2 cells representing L-DC amongst all
CD11b+ and/or CD11c+ myeloid cells was .80% in all cultures
established with D0 to D7 spleens, suggesting that GM-CSF and
IL-4 promote the development of cells of similar
CD11b+CD11c+MHC-II2 phenotype to L-DC (Fig. 3B). Howev-
er, further staining of these CD11b+CD11c+MHC-II2 cells
confirmed that they were not L-DC since they did not express
F4/80, a known L-DC marker (Fig. 4). Some
CD11b+CD11c+MHC-II2 cells expressed Ly6C which also serves
to discount them as L-DC, while cells were also negative for CD8,
expression of Ly6C on a subset is consistent with production of a
CD11clo monocyte-like population.
It seems unlikely therefore that GM-CSF/IL-4 supports the
development of L-DC but may support development of cDC-like
cells and other immature dendritic-like cells (Fig. 4). A subset of
CD11b+CD11c+MHC-II2 cells produced in Flt3L-supplemented
culture, are more reflective of L-DC grown in 5G3 co-cultures, in
that they express F4/80, but not Ly6C [13].
M-CSF Directs DC Differentiation in Stromal Co-cultures
A role for M-CSF in DC development in 5G3 co-cultures was
also investigated, since previous studies have shown high levels of
M-CSF produced by the 5G3 stromal line [6]. The GW2580
inhibitor of M-CSFR was added into co-cultures established from
one-day old spleens of C57BL/6J mice and cell production
compared with controls. The inhibitor was replenished at medium
change every 2 days to maintain the concentration of inhibitor
over 28 days. Cells were collected for analysis of the production of
L-DC and cDC-like cells at 14, 21 and 28 days. Production of cells
was assessed flow cytometrically by gating CD11b+CD11c+ DC,
followed by analysis of expression of MHC-II, 4-1BBL, F4/80,
and CD8 to delineate DC subsets. Cultures produced 2 main
populations of cells, a CD11b+CD11c+ DC population, and a
CD11b2CD11c2 progenitor-containing population (Fig. 5A). The
size of the CD11b2CD11c2 progenitor/precursor-containing
population was notably larger in the presence of inhibitor,
comprising up to 82% of cells across 28 days of co-culture,
compared with ,15% of all cells in control co-cultures (Fig. 5B).
The small subset of CD11b+CD11c+MHC-II+ cDC-like cells (3–
5%) produced in ‘‘no inhibitor’’ controls was distinguishable from
the major population of CD11b+CD11c+MHC-II2 L-DC also
confirmed by their expression of F4/80 and 4-1BBL (Fig. 5A). In
contrast, almost no CD11b+CD11c+MHC-II+ cDC-like cells were
maintained in co-cultures containing the GW2580 inhibitor
(Fig. 5A). Overall, in ‘‘no inhibitor’’ control cultures, ,25 times
more L-DC were produced than cDC-like cells (Fig. 5C). The
effect of the inhibitor was to reduce the production of L-DC by,3
fold, while the production of cDC-like cells was reduced by at least
50-fold (Fig. 5C). These data suggest that M-CSF is important for
the development of only some L-DC, but completely regulates the
production of cDC-like cells and progenitors (Fig. 5B). Since the
size of the progenitor-containing subset increased dramatically in
the presence of GW2580, it appears that M-CSF is an important
regulator not only of the development of cDC-like cells, but also of
progenitor development. Since so few cDC are produced in
control ‘‘no inhibitor’’ cultures, it appears that M-CSF may act as
a negative regulator of progenitor proliferation, while perhaps
supporting progenitor differentiation to c-DC. Upon inhibition of
M-CSF signaling there is a disproportionate increase in the
progenitor pool, in relation to the decrease in production of cDC-
like cells.
Spleen Contains LT-HSC which Produce Only L-DC in
Stromal Co-cultures
Since HSC from BM have previously been shown to represent a
source of L-DC progenitors [17,18], we questioned whether
neonatal spleens contained HSC. T/B depleted spleen cells were
prepared from one-day old mice for analysis and sorting of HSC
and progenitor subsets by antibody staining and flow cytometry.
Live (PI2) cells were gated and mature lineage (Lin+) cells
excluded. Sca-1 versus c-kit expression was used to delineate the
Lin2Sca-1+c-kit+ (LSK) subset (Fig. 6A). Differential expression of
Flt3 and CD150 was then used to divide the LSK subset further.
LT-HSC were identified as Flt32CD150+Lin2Sca-1+c-Kit+ cells,
and MPP as Flt3+CD1502Lin2Sca-1+c-Kit+ cells, based on
previous studies (Fig. 6A) [24,28]. In order to determine the
production of DC, sorted LT-HSC and multipotential progenitors
(MPP) were overlaid on to 5G3 stroma, and cells collected for
analysis at 14, 21 and 28 days. Gating on the CD11b versus
CD11c plot was used to delineate 2 populations evident as DC
(CD11b+CD11c+), and a progenitor-rich (CD11b2CD11c2)
population. The expression of MHC-II, B220, CD8, F4/80 and
4-1BBL also helped to distinguish L-DC (Fig. 6B).
LT-HSC co-cultures maintained .50% CD11b2CD11c2
progenitor-containing subset, with #30% CD11b+CD11c+ DC
produced over 28 days (Figures 6B & 6C). In contrast, MPP co-
cultures maintained a ,15% CD11b2CD11c2 subset and .65%
myeloid cells over this period. In terms of cell numbers, MPP co-
cultures yielded higher numbers of DC than did LT-HSC
cocultures, although lower numbers of progenitors (Fig. 6C). Both
LT-HSC and MPP co-cultures produced only L-DC, consistent
with a model for direct differentiation of L-DC from self-renewing
progenitors present in these 2 subsets (Fig. 7A and 7B). Due to
lower available numbers of LT-HSC in bone marrow, co-cultures
were established with only 103 cells, compared with 104 for MPP.
However, these two progenitor subsets had the same capacity for
production of L-DC, yielding a similar increase in cell output
relative to input cells over time (Fig. 7C).
Discussion
The ontogeny of L-DC development in perinatal spleen has
been investigated with a view to determining the lineage
relationship of these cells with other DC subsets. Phenotypic
analysis of prenatal E18.5 spleen by antibody staining and flow
cytometry revealed the presence of L-DC and other myeloid cells,
but not cDC and pDC. Following birth, L-DC were still present,
but pDC appeared later at 2 days, and cDC only at ,4 days
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following birth. This time course clearly distinguishes L-DC
developmentally from pDC and cDC.
E18.5 spleen cells showed production of only L-DC when co-
cultured with 5G3 splenic stroma. This result is consistent with the
presence of L-DC progenitors in prenatal spleen, and raises the
possibility that L-DC progenitors are laid down during embryo-
genesis reflective of yolk sac-derived HSC and a separate lineage
of DC. This is also consistent with reported higher frequencies of
HSC in neonatal spleen [7,29]. A model for a separate
macrophage lineage arising from primitive HSC has been
developed for tissue macrophages including red pulp macrophages
in spleen [30], although our evidence to date, distinguishes L-DC
from those cells.
In contrast to L-DC, cDC and pDC populations in spleen
derive from described common dendritic progenitors (CDP)
[27,31] or myeloid dendritic progenitors (MDP) [32] in BM,
which lead to DC precursors (pre-DC) which enter spleen via
blood where they mature further [22]. The later development of
pDC and cDC in the perinatal period could be attributed to their
development via pre-DC arising from progenitors resident in BM.
Pre-cDC form in BM and continually migrate to spleen via blood
to serve as a reservoir for splenic cDC development and turnover
[22]. In a similar scenario, tissue-resident monocyte populations
derived from yolk sac progenitors have been defined [33] which
are distinct from blood monocytes/macrophages, the latter arising
from precursors in BM in the adult, entering blood and tissues as
monocytes under inflammation [34]. In the case of L-DC, and also
for residential monocytes, it would appear that hematopoiesis can
occur from endogenous progenitors in spleen.
While there is increasing evidence that spleen contains HSC
even in the steady-state [1,3,4], numbers in the adult are very low.
We have shown this in previous tracing experiments where spleen
cells of both neonatal and adult mice were shown to give broad
lineage reconstitution of myeloid and lymphoid cells following
adoptive transfer into lethally irradiated host mice [36,37]. While
all subsets of DC were found to develop, L-DC did however show
higher representation amongst DC and myeloid cells developing in
spleen suggesting that their development was spleen-specific. Our
previous evidence also shows a distinct phenotype for HSC in 8
day old mouse spleen, being Lin2c-kitloSca-12 cells [35,36]. Flow
cytometric analysis of one day old spleen here has shown the
presence of both LT-HSC and MPP, having phenotypes more
similar to subsets in BM [24,28]. Both LT-HSC and MPP sorted
from one-day old spleen showed restricted differentiative capacity
for L-DC in stromal co-cultures with no evidence for production of
cDC-like cells. At this stage, it is proposed that HSC/MPP in D1
spleen are endogenous to spleen, probably as yolk sac-derived
HSC. Co-culture studies have revealed the direct and restricted
differentiation of L-DC supported by 5G3 stroma which maintains
hematopoiesis for at least 4 weeks, with maintenance of progenitor
cells for that entire period. Evidence that both of the phenotyp-
ically distinct LT-HSC and MPP subsets contain L-DC progen-
itors can be explained by either the presence of two distinct
progenitors for L-DC, or for the two progenitors being develop-
Figure 5. An M-CSFR inhibitor inhibits development of cDC-like cells but not L-DC in neonatal spleen co-cultures. One-day old
splenocytes of C57BL/6J mice were co-cultured with 5G3 stroma in the presence or absence of 10ng/ml GW2580, an inhibitor of M-CSFR, added to
cultures at medium change every 3–4 days. (A) Cell production was analysed at 14, 21 and 28 days, by staining cells for CD11c, CD11b, MHC-II, 4-
1BBL, F4/80 and CD8, followed by flow cytometric analysis. Propidium iodide staining was used to delineate live (PI2) cells, which were then gated on
CD11c and CD11b using isotype controls to set gates. L-DC were then distinguished from cDC-like cells on the basis of expression of 4-1BBL, F4/80
and absence of MHC-II expression. Results from one representative culture out of 3 replicates is shown. (B) Co-cultures were analysed over time for
production of CD11b+ cells which differed in expression of CD11c, as well as the CD11b2CD11c2 progenitor-containing subset. (C) Relative
production of CD11b+CD11c+MHC-II2 L-DC and CD11b+CD11c+MHC-II+ cDC-like cells was monitored over time in terms of absolute number of cells
produced. Values represent mean 6 S.E. of three replicate cultures established from individual mice.
doi:10.1371/journal.pone.0088311.g005
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mentally linked, such that one is the precursor of the other. This
hypothesis has been proposed previously in a separate study of
BM-derived L-DC progenitors [18].
Further evidence for lineage distinction between L-DC and
cDC is that M-CSF is essential for cDC-like cell development, but
redundant for L-DC development. This is consistent with different
pathways for development, and probably the existence of distinct
progenitors. All of these findings are consistent with evidence that
L-DC but not cDC progenitors are present amongst LT-HSC
sorted from BM as described previously [17,18], or from D1
spleen as shown here. Whether splenic LT-HSC actually
differentiate to give L-DC progenitors or even CDP in the splenic
microenvironment, is still an open question.
The production of L-DC in cultures of perinatal spleen
supplemented with Flt3L or GM-CSF/IL-4 was also investigated
in relation to production of other DC like cDC. Indeed, Flt3L and
GM-CSF/IL-4 have been used in many labs to grow out
populations of DC from BM cells in vitro. DC developing in
GM-CSF/IL-4 have been described as CD11c+MHC-II+ DC, and
used for the study of immune responses in both mice and humans
for over a decade [38,39]. Flt3L addition to BM cells has been
shown to induce the production of both cDC and pDC [27,40].
Recently, Xu et al [26] compared DC production in BM due to
Flt3L and GM-CSF and showed that Flt3L induced cDC and
pDC, while GM-CSF induced monocyte-derived inflammatory
DC [26]. When neonatal or adult spleen cells were cultured with
Flt3L and GM-CSF/IL-4, they induced a range of cells expressing
CD11c and MHC-II. The capacity of Flt3L to maintain myeloid
DC (CD11b+CD11c+) was lower than that of GM-CSF/IL-4,
suggesting that GM-CSF/IL-4 may be superior in DC expansion
from existing precursors. However, since CD11b+CD11c+MHC-
II+ cells were produced here from spleen cells in Flt3L
supplemented cultures, a high number of Flt3+ DC precursors
must be present amongst spleen cells. GM-CSF/IL-4 also induced
a significant proportion of CD11b+CD11c+MHC-II2 cells in
cultures which do not appear to be L-DC in that they are F4/
802Ly6C+ cells and so may reflect monocytic cells rather than L-
DC (Figure 4B). F4/80 was recently shown to be a marker for L-
DC in vivo and in vitro (Fig. 6; unpublished data). Flt3L supple-
mented cultures did produce a subset of CD11b+CD11c+MHC-
II2F4/80+ cells. It would appear therefore that Flt3L can support
L-DC production, as well as the production of cDC and
monocyte-like cells.
Overall, the emergence of L-DC in prenatal spleen prior to the
appearance of pDC and cDC, and their lack of M-CSF
dependency, distinguishes them as antigen presenting cells in
spleen. The possibility that they derive from spleen-endogenous
self-renewing HSC and MPP is supported by evidence that LT-
HSC and MPP subsets from D1 spleen also contain L-DC
progenitors. Indeed, the presence of the L-DC subset in embryonic
and newborn spleen supports a model for tissue-specific dendri-
topoiesis occurring in spleen. This is a new phenomenom which
would support a model for compartmentalisation of the immune
response with tissue-specific antigen presenting cells.
Figure 6. LT-HSC in neonatal spleen contribute to DC production in stromal co-cultures. (A) Spleen cells isolated from one-day old C5BL/
6J mice were stained with antibodies to distinguish hematopoietic progenitors flow cytometrically. A lineage cocktail of antibodies (CD3, CD4, CD5,
CD8, B220, Gr-1, CD11b, Ter119, CD11c) was used to exclude mature Lin+ cells. Staining with Propidium iodide (PI:1ugm/ml) was used to delineate
PI2 live cells. Sca-1 and c-kit staining was used to identify the Lin2c-kit+Sca-1+(LSK) subset. Staining with Flt3 and CD150 was used to distinguish and
sort LT-HSC and MPP, which were overlaid in co-cultures above 5G3 stroma. (B) Non-adherent cells produced in co-cultures were stained with
antibodies to detect a CD11b+CD11c+ population of dendritic-like cells. These were tested for expression of MHC-II, 4-1BBL, F4/80, CD24, CD8, and
B220 to delineate L-DC and cDC-like subsets. Data show cell production at 21 days for one of three replicate cultures established from different mice.
Gates were set on bivariate plots using isotype control antibodies and numbers on gates reflect % positive cells. (C) Production of CD11b2CD11c2
progenitors and CD11b+CD11c+ dendritic-like cells was calculated in terms of proportion of each subset and number of cells of each type produced.
Graphs show mean6S.E. for triplicate co-cultures.
doi:10.1371/journal.pone.0088311.g006
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